BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15734661)

  • 1. Cryptosporidium excystation and invasion: getting to the guts of the matter.
    Smith HV; Nichols RA; Grimason AM
    Trends Parasitol; 2005 Mar; 21(3):133-42. PubMed ID: 15734661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labeling surface epitopes to identify Cryptosporidium life stages using a scanning electron microscopy-based immunogold approach.
    Edwards H; Thompson RC; Koh WH; Clode PL
    Mol Cell Probes; 2012 Feb; 26(1):21-8. PubMed ID: 22100878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptosporidium infections: molecular advances.
    Lendner M; Daugschies A
    Parasitology; 2014 Sep; 141(11):1511-32. PubMed ID: 24679517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active invasion and/or encapsulation? A reappraisal of host-cell parasitism by Cryptosporidium.
    Borowski H; Clode PL; Thompson RC
    Trends Parasitol; 2008 Nov; 24(11):509-16. PubMed ID: 18801703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Hommer V; Eichholz J; Petry F
    J Antimicrob Chemother; 2003 Sep; 52(3):359-64. PubMed ID: 12888587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets for detection and immunotherapy in Cryptosporidium parvum.
    Boulter-Bitzer JI; Lee H; Trevors JT
    Biotechnol Adv; 2007; 25(1):13-44. PubMed ID: 17055210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptosporidium: a water-borne zoonotic parasite.
    Fayer R
    Vet Parasitol; 2004 Dec; 126(1-2):37-56. PubMed ID: 15567578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host intestinal epithelial response to Cryptosporidium parvum.
    Deng M; Rutherford MS; Abrahamsen MS
    Adv Drug Deliv Rev; 2004 Apr; 56(6):869-84. PubMed ID: 15063595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptosporidia--who is at risk?
    Keusch GT; Hamer D; Joe A; Kelley M; Griffiths J; Ward H
    Schweiz Med Wochenschr; 1995 May; 125(18):899-908. PubMed ID: 7770751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum.
    Bushen OY; Kohli A; Pinkerton RC; Dupnik K; Newman RD; Sears CL; Fayer R; Lima AA; Guerrant RL
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):378-84. PubMed ID: 16934303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Glycosaminoglycans on
    Mayerberger EA; Yazdanparast Tafti S; Jedlicka SS; Jellison KL
    Appl Environ Microbiol; 2023 Mar; 89(3):e0173722. PubMed ID: 36790186
    [No Abstract]   [Full Text] [Related]  

  • 12. Excystation of Cryptosporidium parvum at temperatures that are reached during solar water disinfection.
    Gómez-Couso H; Fontán-Sainz M; Fernández-Alonso J; Ares-Mazás E
    Parasitology; 2009 Apr; 136(4):393-9. PubMed ID: 19195413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissection of the hierarchy and synergism of the bile derived signal on Cryptosporidium parvum excystation and infectivity.
    King BJ; Keegan AR; Phillips R; Fanok S; Monis PT
    Parasitology; 2012 Oct; 139(12):1533-46. PubMed ID: 22894830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptosporidium parvum.
    Dumaine JE; Tandel J; Striepen B
    Trends Parasitol; 2020 May; 36(5):485-486. PubMed ID: 31836286
    [No Abstract]   [Full Text] [Related]  

  • 15. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
    Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
    Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptosporidium cell culture infectivity assay design.
    King BJ; Keegan AR; Robinson BS; Monis PT
    Parasitology; 2011 May; 138(6):671-81. PubMed ID: 21414244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptosporidium: molecular basis of host-parasite interaction.
    Ward H; Cevallos AM
    Adv Parasitol; 1998; 40():151-85. PubMed ID: 9554073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete development of Cryptosporidium parvum in host cell-free culture.
    Hijjawi NS; Meloni BP; Ng'anzo M; Ryan UM; Olson ME; Cox PT; Monis PT; Thompson RC
    Int J Parasitol; 2004 Jun; 34(7):769-77. PubMed ID: 15157759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
    Dugue GA
    J Antimicrob Chemother; 2004 Feb; 53(2):403; author reply 403. PubMed ID: 14729752
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptation of Cryptosporidium oocysts to different excystation conditions.
    Widmer G; Klein P; Bonilla R
    Parasitology; 2007 Oct; 134(Pt 11):1583-8. PubMed ID: 17506930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.